ENTEROBACTERIAL CHELATORS OF IRON: THEIR OCCURRENCE, DETECTION, AND RELATION TO PATHOGENICITYMILES AA; KHIMJI PL.1975; J. MED. MICROBIOL.; G.B.; DA. 1975; VOL. 8; NO 4; PP. 477-490; H.T. 2; BIBL. 1 P.Article

Recovery of Nickel from Spent Industrial Catalysts Using Chelating AgentsVUYYURU, Koteswara R; PANT, Kamal K; KRISHNAN, Venkatesan V et al.Industrial & engineering chemistry research. 2010, Vol 49, Num 5, pp 2014-2024, issn 0888-5885, 11 p.Article

Effect of dithiothreitol on agonist and antagonist actions in frog muscleBLEEHEN, T; CLARK, A. L; HOBBIGER, C. F et al.Journal of pharmacy and pharmacology. 1983, Vol 35, Num 10, pp 660-665, issn 0022-3573Article

Extraction of Nickel from Spent Catalyst Using Biodegradable Chelating Agent EDDSCHAUHAN, Garima; PANT, Kamal K; NIGAM, Krishna D. P et al.Industrial & engineering chemistry research. 2012, Vol 51, Num 31, pp 10354-10363, issn 0888-5885, 10 p.Article

À propos d'un cas d'intoxication volontaire à l'arsenic = Arsenic self-poisoning: A case reportSALOMON, A; DETAVE, M; FIEVET, A et al.Annales françaises d'anesthésie et de réanimation. 2012, Vol 31, Num 11, pp 928-929, issn 0750-7658, 2 p.Article

THE DEVELOPMENT OF NEW IRON-CHELATING DRUGS = LE DEVELOPPEMENT DE NOUVEAUX AGENTS CHELATEURS DU FERGRADY RW; GRAZIANO JH; AKERS HA et al.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 196; NO 2; PP. 478-485; BIBL. 36 REF.Article

Clinical evaluation of deferasirox (Exjade®, ICL670)PORTER, John.Seminars in hematology. 2007, Vol 44, Num 2, issn 0037-1963, S16-S20, SUP3Article

A novel approach to radioassays using bifunctional conjugates and terminal labelingHARWIG, J. F; OFLAZ, G; ÓBRIEN, T. J et al.International journal of nuclear medicine & biology. 1983, Vol 10, Num 4, pp 263-268, issn 0047-0740Article

Teratogenesis and low copper status resulting from triethylenetetramine in ratsKEEN, C. L; COHEN, N. L; LONNERDAL, B et al.Proceedings of the Society for Experimental Biology and Medicine. 1983, Vol 173, Num 4, pp 598-605, issn 0037-9727Article

Oral Iron ChelatorsKWIATKOWSKI, Janet L.Hematology/oncology clinics of North America. 2010, Vol 24, Num 1, issn 0889-8588, x, 229-248 [21 p.]Article

High-performance liquid chromatographic analysis of desferrioxamine using a metal-free systemVENKATARAM, S; RAHMAN, Y. E.Journal of chromatography. 1987, Vol 411, pp 494-497, issn 0021-9673Article

Deferasirox (Exjade®, ICL670) preclinical overviewNICK, Hanspeter.Seminars in hematology. 2007, Vol 44, Num 2, issn 0037-1963, S12-S15, SUP3Article

KINETIC STUDIES ON INHIBITION OF AMINOPROPYLTRANSFERASE BY AURINTRICARBOXYLIC ACID IN VITROHIRASAMI H; TANAKA M; NAGAI J et al.1982; CHEMICO-BIOLOGICAL INTERACTIONS; ISSN 0009-2797; NLD; DA. 1982; VOL. 40; NO 3; PP. 319-323; BIBL. 10 REF.Article

SCHWERE NEBENWIRKUNGEN BEI DER THERAPIE MIT D-PENICILLAMIN. = EFFETS SECONDAIRES GRAVES APRES TRAITEMENT PAR LA D-PENICILLAMINEHENNEMANN HH; HUBERTUS H; STOCKER WG et al.1975; DTSCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 32; PP. 1634-1638; ABS. ANGL; BIBL. 24 REF.Article

NITRILOTRIACETIC ACID AS A CHELATING AGENT. APPLICATIONS, TOXICOLOGY, AND BIO-ENVIRONMENTAL IMPACTMOTTOLA HA.1974; TOXICOL. ENVIRONMENT. CHEM. REV.; G.B.; DA. 1974; VOL. 2; NO 2; PP. 99-161; BIBL. 14P.1/2Article

SYNTHESE UND REINHEITSPRUEFUNG VON PENICILLAMIN-(2-¹⁴C) = SYNTHESE ET ESSAI DE PURETE DE LA PENICILLAMINE-(₂¹⁴C)DONNERT D; PLANAS BOHNE F.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 9; PP. 1423-1425; ABS. ANGL.; BIBL. 10REF.Serial Issue

METABOLISMUS UND TOXIZITAET THERAPEUTISCHER CHELATBILDNER. XIV. WIRKUNG VON DTPA AUF DIE HAEMATOPOESE = METABOLISME ET TOXICITE DES FORMATEURS DE CHELATES EMPLOYES EN THERAPEUTIQUE. XIV. L'ACTIVITE DE L'ACIDE DIETHYLENE PENTA AMINE TETRAACETIQUE SUR L'HEMATOPOIESEEBEL H.1975; STRAHLENTHERAPIE; DTSCH.; DA. 1975; VOL. 149; NO 4; PP. 450-456; ABS. ANGL. FR.; BIBL. 21REF.Article

ETUDE TOXICOLOGIQUE EXPERIMENTALE DE QUELQUES DERIVES ARGENTIQUES. II. ETUDE DE L'ACTION DE CERTAINES SUBSTANCES DITES DETOXICANTESDEQUIDT J; VASSEUR P; GROMEZ POTENTIER J et al.1974; BULL. SOC. PHARM. LILLE; FR.; DA. 1974; NO 1; PP. 35-44; BIBL. 4REF.Article

PENICILLAMINE IN THE TREATMENT OF RHEUMATOID ARTHRITISHUSKISSON EC; HART FD.1972; ANN. RHEUMAT. DIS.; G.B.; DA. 1972; VOL. 31; NO 5; PP. 402-404; BIBL. 4REF.Serial Issue

Biologically useful chelators that release Ca²⁺ upon illuminationADAMS, S. R; KAO, J. P. Y; GRYNKIEWICZ, G et al.Journal of the American Chemical Society. 1988, Vol 110, Num 10, pp 3212-3220, issn 0002-7863Article

Rétine et épithélium pigmentaire : Le desferalROULEZ, F.Bulletin de la Société belge d'ophtalmologie. 2007, Num 304, pp 59-66, issn 0081-0746, 8 p.Article

RELEASE OF MACROMOLECULES FROM BALB/C MOUSE CELL LINES TREATED WITH CHELATING AGENTSCULP LA; BLACK PH.1972; BIOCHEMISTRY; U.S.A.; DA. 1972; VOL. 11; NO 11; PP. 2161-2172; BIBL. 27REF.Serial Issue

ATTACHMENT OF FLUORESCENT METAL CHELATES TO MACROMOLECULES USING "BIFUNCTIONAL" CHELATING AGENTS.LEUNG CSH; MEARES CF.1977; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1977; VOL. 75; NO 1; PP. 149-155; BIBL. 18 REF.Article

Specific iron chelators determine the route of ferritin degradationDE DOMENICO, Ivana; MCVEY WARD, Diane; KAPLAN, Jerry et al.Blood. 2009, Vol 114, Num 20, pp 4546-4551, issn 0006-4971, 6 p.Article

La chélation du fer = Iron chelation therapyTRABELSI, M; TINSA, F; LAKHOUA, M. R et al.Revue maghrébine de pédiatrie. 2003, Vol 13, Num 4, pp 171-175, issn 0330-7611, 5 p.Article